Medmain Inc. is a company specializing in the development of software solutions for pathology diagnosis, founded in 2018 and headquartered in Fukuoka City, Japan, with additional offices in Tokyo and the United States. The company offers a range of products, including PidPort, which utilizes machine learning and artificial intelligence for rapid pathology diagnosis, and Medteria, an online platform providing educational resources for medical students. Medmain's technology enhances operational efficiency for medical institutions by facilitating accurate pathological image analysis and supporting telepathology consultations. Their innovative solutions also assist pharmaceutical companies and contract research organizations in drug discovery efforts, promoting collaboration through online diagnostic platforms and conferences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.